Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
marco.salvetti@uniroma1.it
Marco Salvetti
Professore Ordinario
Struttura:
DIPARTIMENTO DI NEUROSCIENZE, SALUTE MENTALE E ORGANI DI SENSO
E-mail:
marco.salvetti@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Treatment modifiers across different regimens of natalizumab treatment in MS: An Italian real-world experience
NEUROTHERAPEUTICS
2024
Disentangling multiple sclerosis phenotypes through Mendelian disorders: A network approach
MULTIPLE SCLEROSIS
2024
Co-existence of Myelin Oligodendrocyte Glycoprotien Antibody-associated Disease (MOGAD) and Spinocerebellar Ataxia type 1 (SCA1): A case report
NEUROLOGICAL SCIENCES
2024
Peripheral Biomarkers in Manifest and Premanifest Huntington’s Disease
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2023
Sars-CoV2 infection in pregnant women with multiple sclerosis
MULTIPLE SCLEROSIS
2023
Antibody response elicited by the SARS-CoV-2 vaccine booster in patients with multiple sclerosis: Who gains from it?
EUROPEAN JOURNAL OF NEUROLOGY
2023
Frailty and relapse activity in multiple sclerosis: A longitudinal observation
MULTIPLE SCLEROSIS AND RELATED DISORDERS
2023
Comparison of quantitative muscle ultrasound and whole-body muscle MRI in facioscapulohumeral muscular dystrophy type 1 patients
NEUROLOGICAL SCIENCES
2023
Quantitative sensory testing and skin biopsy findings in late‐onset ATTRv pre‐symptomatic carriers: relationships with predicted time of disease onset (PADO)
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
2023
The value of Interferon β in multiple sclerosis and novel opportunities for its anti-viral activity: a narrative literature review
FRONTIERS IN IMMUNOLOGY
2023
Tissue factor as a potential coagulative/vascular marker in relapsing-remitting multiple sclerosis
FRONTIERS IN IMMUNOLOGY
2023
Eculizumab for myasthenic exacerbation during treatment with immune-checkpoint inhibitors
NEUROLOGICAL SCIENCES
2023
Cerebral hemodynamics and cognitive functions in the acute and subacute stage of mild ischemic stroke: a longitudinal pilot study
NEUROLOGICAL SCIENCES
2023
Cladribine and ocrelizumab induce differential miRNA profiles in peripheral blood mononucleated cells from relapsing-remitting multiple sclerosis patients
FRONTIERS IN IMMUNOLOGY
2023
Response to “Frailty in multiple sclerosis: A closer look at the deficit accumulation framework”
MULTIPLE SCLEROSIS
2022
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study
MULTIPLE SCLEROSIS
2022
A clinical and epidemiological prevalence study on Friedreich’s Ataxia in Latium, Italy
NEUROEPIDEMIOLOGY
2022
Multiple sclerosis genetic and non-genetic factors interact through the transient transcriptome
SCIENTIFIC REPORTS
2022
Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy
EBIOMEDICINE
2022
Late-Onset MS: Disease Course and Safety-Efficacy of DMTS
FRONTIERS IN NEUROLOGY
2022
1
2
3
4
5
6
7
8
seguente ›
ultima »
Progetti di Ricerca
Looking for final effectors of regulome alterations in MS: LMP1-mediated dysregulation of AID in MS pathogenesis
Epstein-Barr virus genotypes in multiple sclerosis
Impact of genetic and non-genetic risk factors for MS on regulatory RNAs.
Laboratori di ricerca
Laboratori di Colture Cellulari 2
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma